Myocardial metabolic flexibility and myocardial function in patients with complicated type 2 diabetes

ISRCTN ISRCTN72259923
DOI https://doi.org/10.1186/ISRCTN72259923
Protocol serial number P05.195
Sponsor Leiden University Medical Center (Netherlands)
Funders Center for Translational Molecular Medicine (Netherlands) [project PREDICCt (grant 01C-104)], The Netherlands Heart Foundation (Netherlands), Dutch Diabetes Research Foundation (Netherlands), Dutch Kidney Foundation (Netherlands)
Submission date
09/03/2011
Registration date
30/03/2011
Last edited
06/01/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof J.W.A. Smit
Scientific

Leids Universitair Medisch Centrum
Albinusdreef 2
Leiden
2333 ZA
Netherlands

Study information

Primary study designInterventional
Study designProspective intervention study
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleMyocardial metabolic flexibility and myocardial function in patients with complicated type 2 diabetes: a prospective intervention study
Study objectivesTo assess the effect of a short term very low calorie diet on myocardial triglyceride content and myocardial function in patients with complicated type 2 diabetes mellitus
Ethics approval(s)Medical Ethics Committee of the Leiden University Medical Centre, approved on 4th August 2008, reference: P05.195/SH
Health condition(s) or problem(s) studiedType 2 diabetes mellitus
InterventionTwo magnetic resonance imaging (MRI)-scans will be performed in all patients. One baseline MRI-scan will be performed while patients have used their regular diet. A second MRI-scan after a 3-day very low calorie diet (450 kcal/day) (VLCD). During the VLCD the glucose lowering medication is adjusted to prevent hypoglycemia.
Intervention typeOther
Primary outcome measure(s)

1. Myocardial triglcyeride content measured using proton MR spectroscopy
2. Cardiac function-measured by MRI

Measured at baseline and at day 4

Key secondary outcome measure(s)

1. Plasma free fatty acids-blood tests
2. Plasma glucose-blood tests
3. Waist fat

Measured at baseline and at day 4

Completion date01/01/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration17
Key inclusion criteriaPatients with complicated type 2 diabetes mellitus, both men and women, age >18 years
Key exclusion criteria1. Myocardial infarction
2. Congenital cardiac disease
3. Kidney failure
4. Pregnancy or lactation
5. Contra-indications for magnetic resonance imaging (MRI)
Date of first enrolment10/02/2009
Date of final enrolment01/01/2011

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Leids Universitair Medisch Centrum
Leiden
2333 ZA
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2014 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes